Mazzo David J
SEC-identified person · CIK 1334549 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Phase III Medical INC/DE PHSM | Director · President & CEO | filed 2015 - 2026 |
| Seneca Biopharma, Inc. SNCA | Director | filed 2019 - 2021 |
| Psivida LTD PSDV | Director | filed 2007 - 2020 |
| Avanir Pharmaceuticals, INC. AVNR | Director | filed 2006 - 2014 |
| Tobira Therapeutics, Inc. TBRA | Director · President and CEO | filed 2013 - 2014 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.